Have a personal or library account? Click to login
Association of C5a/C5aR pathway to activate ERK1/2 and p38 MAPK in acute kidney injury – a mouse model Cover

Association of C5a/C5aR pathway to activate ERK1/2 and p38 MAPK in acute kidney injury – a mouse model

By: Zeying Zhang  
Open Access
|Feb 2022

References

  1. 1. Gyal A, Daneshpajouhnejad P, Hashmi M. F, Bashir K. Acute Kidney Injury. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan; PMID: 28722925.
  2. 2. Ostermann M, Liu K. Pathophysiology of AKI. Best Pract Res Clin Anaesthesiol. 2017 Sep; 31(3):305-14. DOI: 10.1016/j.bpa.2017.09.00110.1016/j.bpa.2017.09.001
  3. 3. Lande R. E, Blackburn R. Evaluating pharmacist training. Popul Rep J. 1989 Nov;(37):26-8.
  4. 4. Pei G, Zhang Z. Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia. J Am Soc Nephrol. 2020 Jun; 31(6):1157-65. DOI: 10.1681/ASN.202003027610.1681/ASN.2020030276
  5. 5. Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020 Mar; 31(368):m1091. DOI: 10.1136/bmj.m109110.1136/bmj.m1091
  6. 6. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020 Mar; 395(10229):1054-62. DOI: 10.1016/S0140-6736(20)30566-310.1016/S0140-6736(20)30566-3
  7. 7. Cao J, Tu WJ, Cheng W, Yu L, Liu YK, Hu X, et al. Clinical Features and Short-term Outcomes of 102 Patients with Coronavirus Disease 2019 in Wuhan, China. Clin Infect Dis. 2020 Jul; 71(15):748-55. DOI: 10.1093/cid/ciaa24310.1093/cid/ciaa243718447932239127
  8. 8. Hirsch JS, Ng JH, Ross DW, Sharma P, Shah HH, Barnett RL, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020 Jul; 98(1):209-18. DOI: 10.1016/j.kint.2020.05.00610.1016/j.kint.2020.05.006722946332416116
  9. 9. Nishida K, Watanabe H, Miyahisa M, Hiramoto Y, Nosaki H, Fujimura R, et al. Systemic and sustained thioredoxin analogue prevents acute kidney injury and its-associated distant organ damage in renal ischemia reperfusion injury mice. Sci Rep. 2020 Nov; 10(1):20635. DOI: 10.1038/s41598-020-75025-510.1038/s41598-020-75025-5769134333244034
  10. 10. Nadim MK, Forni LG, Mehta RL, Connor MJ, Liu KD, Ostermann M, et al. COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. Nat Rev Nephrol. 2020 Dec,16(12):747-74. DOI: 10.1038/s41581-020-00356-510.1038/s41581-020-00356-5756124633060844
  11. 11. Markiewski MM, Lambris JD. The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am J Pathol. 2007 Sep;171(3):715-27. DOI: 10.2353/ajpath.2007.07016610.2353/ajpath.2007.070166195948417640961
  12. 12. Jeon H, Han SR, Lee S, Park SJ, Kim JH, Yoo SM, et al. Activation of the complement system in an osteosarcoma cell line promotes angiogenesis through enhanced production of growth factors. Sci Rep. 2018 April; 8:5415. DOI: 10.1038/s41598-018-23851-z10.1038/s41598-018-23851-z588303329615744
  13. 13. Liu XY, Wang XY, Li RY, Jia SC, Sun P, Zhao M, et al. Recent progress in the understanding of complement activation and its role in tumor growth and anti-tumor therapy. Biomed Pharmacother. 2017Jul; 91:446-56. DOI: 10.1016/j.biopha.2017.04.10110.1016/j.biopha.2017.04.10128477461
  14. 14. Afshar-Kharghan V. The role of the complement system in cancer. J Clin Invest. 2017 Mar; 127(3):780-9. DOI: 10.1172/JCI9096210.1172/JCI90962533075828248200
  15. 15. Schraufstatter IU, Trieu K, Sikora L, Sriramarao P, DiScipio R. Complement c3a and c5a induce different signal transduction cascades in endothelial cells. J Immunol. 2002 Aug; 169(10):2102-10. DOI: 10.4049/jimmunol.169.4.210210.4049/jimmunol.169.4.210212165538
  16. 16. Monsinjon T, Gasque P, Chan P, Ischenko A, Brady JJ, Fontaine MC. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells. Faseb j. 2003 Jun;17(9):1003-14. DOI: 10.1096/fj.02-0737com10.1096/fj.02-0737com12773483
  17. 17. Rousseau S, Dolado I, Beardmore V, Shpiro N, Marquez R, Nebreda AR, et al. CXCL12 and C5a trigger cell migration via a PAK1/2-p38alpha MAPK-MAPKAP- K2-HSP27 pathway. Cell Signal. 2006 Nov; 18(11):1897-905. DOI: 10.1016/j.cellsig.2006.02.00610.1016/j.cellsig.2006.02.00616574378
  18. 18. Markiewski MM, DeAngelis RA, Strey CW, Foukas PG, Gerard C, Gerard N, et al. The regulation of liver cell survival by complement. J Immunol. 2009 May; 182(9):5412-8. DOI: 10.4049/jimmunol.080417910.4049/jimmunol.0804179273212819380788
  19. 19. Albert-Gascó H, Ros-Bernal F. MAP/ERK Signaling in Developing Cognitive and Emotional Function and Its Effect on Pathological and Neurodegenerative Processes. Int J Mol Sci. 2020 Jun; 21(12):4471. DOI: 10.3390/ijms2112447110.3390/ijms21124471735286032586047
  20. 20. El Rawas R, Amaral IM. Is p38 MAPK Associated to Drugs of Abuse-Induced Abnormal Behaviors? Int J Mol Sci. 2020 Jul; 21(14):4833. DOI:10.3390/ijms 21144833. DOI: 10.3390/ijms10.3390/ijms
  21. 21. Sun Y, Liu WZ, Liu T, Feng X, Yang N, Zhou HF. Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Res. 2015 Jun; 35(6):600-4. DOI: 10.3109/10799893.2015.103041210.3109/10799893.2015.103041226096166
  22. 22. Davidson SM, Arjun S, Basalay MV, Bell RM, Bromage DI, Bøtker HE, et al. The 10th Biennial Hatter Cardiovascular Institute workshop: cellular protection-evaluating new directions in the setting of myocar-dial infarction, ischaemic stroke, and cardio-oncology. Basic Res Cardiol 2018 Oct; 113(6):43. DOI: 10.1007/s00395-018-0704-z10.1007/s00395-018-0704-z618268430310998
  23. 23. Dong Q, Jie Y, Ma J, Li C, Xin T, Yang D. Renal tubular cell death and inflammation response are regulated by the MAPK-ERK-CREB signaling pathway under hypoxia-reoxygenation injury. J Recept Signal Transduct Res. 2019 Oct-Dec; 39(5-6):383-91. DOI: 10.1080/10799893.2019.169805010.1080/10799893.2019.1698050
  24. 24. Levey AS, James MT. Acute Kidney Injury. Ann Intern Med. 2017 Nov; 167(9):ITC66-80. DOI: 10.7326/AITC20171107010.7326/AITC201711070
  25. 25. Polycarpou A, Howard M, Farrar CA, Greenlaw R, Fanelli G. Rationale for targeting complement in COVID-19. EMBO Mol Med. 2020 Aug; 12(8):e12642. DOI: 10.15252/emmm.20201264210.15252/emmm.202012642
  26. 26. Hammerschmidt DE, Weaver LJ, Hudson LD, Crad-dock PR, Jacob HS. Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Pathophysiological relevance and possible prognostic value. Lancet 1980 May; 1(8175):947-9. DOI: 10.1016/S0140-6736(80)91403-810.1016/S0140-6736(80)91403-8
  27. 27. Rittirsch D, Flierl MA, Nadeau BA, Day DE, Huber-Lang M, Mackay CR, et al. Functional roles for C5a receptors in sepsis. Nat Med. 2008 May; 14(5):551-7. DOI: 10.1038/nm175310.1038/nm1753275385818454156
  28. 28. Skausig O. B, Lversen O. Severe paresis caused by electrolyte disturbances following end-to-side jejunoileostomy for morbid obesity. Dan Med Bull. 1979 Nov;26(7):344-5.
  29. 29. Tsai JP, Lee CJ, Subeq YM, Lee RP, Hsu BG. Acute Alcohol Intoxication Exacerbates Rhabdomyolysis-Induced Acute Renal Failure in Rats. Int J Med Sci. 2017 Jun 23;14(7):680-9. DOI: 10.7150/ijms.19479.10.7150/ijms.19479556212028824301
DOI: https://doi.org/10.2478/rrlm-2022-0001 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Language: English
Page range: 31 - 40
Submitted on: Aug 20, 2021
|
Accepted on: Dec 7, 2021
|
Published on: Feb 12, 2022
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2022 Zeying Zhang, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution 4.0 License.